Beamline Diagnostics Limited

Overview

Legal name

BEAMLINE DIAGNOSTICS LIMITED

Region

Unknown

Registered address

Unknown

Insolvency history

Yes

Company events

Reference milestones and recent Companies House filing stream events.

1 event

23 Mar

2015

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards

First funded

2016

Funded years

2016, 2018

Age at first award

1 years

Projects

2018 Collaborative R&D

Solas-Lung

1 Nov 2018 to 30 Jun 2021

Awarded

£465,560

Total cost £665,083

_Solas-Lung_ reinforces a partnership between BeamLine and University College London (UCL) with the primary project aim to complete the 400 patient first in clinic trial required for developing our technology towards regulatory approval: advancing _Solas-Lung_ to TRL6/7\. UCL have supported IR detection of cancerous cells with \>10 years of ground-breakin...

2016 GRD Proof of Market Lead participant

Rapid, Point-of-Care Screening of Biopsies for Pre-Cancer of the Gastrointestinal Tract

1 Apr 2016 to 31 Jul 2016

Awarded

£24,136

Total cost £40,226

In 2012, 1.4 million biopsy procedures were performed to test for cancer in NHS England alone. Each procedure generates typically between 4 and 40 biopsies, each of which must undergo histological examination. Depending on the cancer type, between 90 and 99% of these biopsies are healthy or do not indicate the need for further intervention. The large numb...

Product types

Collaborative R&D GRD Proof of Market